Hydrolysis-Sensitive Dithiolethione Prodrug Micelles.

Area of Science:

• Biotechnology
• Materials Science
• Oncology

Background:

• 5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione (ADT-OH) exhibits chemopreventive properties relevant to cancer therapy.
• Developing effective drug delivery systems is crucial for optimizing the therapeutic potential of compounds like ADT-OH.
• Prodrug strategies can enhance drug stability, solubility, and targeted delivery.

Purpose of the Study:

• To synthesize and characterize novel prodrug micelles encapsulating ADT-OH using amphiphilic block copolymers.
• To investigate the influence of different linker molecules (glycine and isoleucine) on ADT-OH release kinetics and micelle toxicity.
• To evaluate the potential of these prodrug micelles for cancer therapy and prevention applications.

Main Methods:

• Preparation of prodrug micelles (PAM-PGlyADT and PAM-PIleADT) by linking ADT-OH via ester bonds to amphiphilic block copolymers with glycine and isoleucine linkers.
• Assessment of ADT-OH release rates from both types of micelles.
• Evaluation of the cytotoxicity of the prodrug micelles and free ADT-OH against various cancer cell lines.

Main Results:

• Prodrug micelles were successfully prepared using glycine (PAM-PGlyADT) and isoleucine (PAM-PIleADT) linkers.
• PAM-PIleADT micelles demonstrated significantly slower release of ADT-OH compared to PAM-PGlyADT micelles.
• PAM-PGlyADT micelles exhibited toxicity comparable to free ADT-OH, while PAM-PIleADT micelles showed no toxicity up to 400 µM.

Conclusions:

• The ADT-ester prodrug micelle approach allows for tunable control over the release rate of the chemopreventive agent ADT-OH.
• The choice of linker significantly impacts both drug release kinetics and the resulting micelle's cytotoxicity.
• These findings suggest promising applications for modulated ADT-OH delivery systems in cancer prevention and treatment strategies.